WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware Read more
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age Read more
NeurOp Receives FDA Orphan Drug Designation for NP10679 for Treatment of Subarachnoid Hemorrhage Read more
Recipharm secures supply of drug substance and commences manufacture of chloroquine phosphate Read more
Lonza Supporting Rocket Pharma with Clinical Manufacturing of RP-L201 for the Treatment of Leukocyte Adhesion Deficiency-I Read more
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology Read more